Anti-Human CD147 Therapeutic Antibody (Gavilimomab)
Recombinant monoclonal antibody to CD147. Gavilimomab (also known as ABX-CBL) is a mouse monoclonal antibody intended for use as an immunosuppressive biologic treatment of glucocorticoid-resistant graft versus host disease. It binds to the antigen CD147. Gavilimomab proved slightly less effective than standard antithymocyte globulin therapy.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-156 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD147 |
| Species Reactivity | Human |
| Type | IgM |
| Applications | Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods. |
| Storage | At -20°C for one year. |